Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Humble but confident.
RNVA https://www.globenewswire.com/en/news-release/2023/08/21/2728714/0/en/RENNOVA-HEALTH-INC-PROVIDES-UPDATE-AFTER-FILING-2023-SECOND-QUARTER-FINANCIAL-STATEMENTS.html
Mick, the depressed OTC market may not be able to hold this one down.
RNVA will lead.
Absolutely. RNVA is beginning to attract new investors who actually read earnings reports. RNVA should break out of the 000s based on the current EPS, pennies on the Jamestown duplication of the existing CAH model. RNVA really is a BFD.
Only 73k changed hands so far today. About 10% of the float.
Just getting started.
Good lick.
The CEO has consistently understated his forward guidance since I first started accumulating (last summer when CAH revenues began kicking in).
Word hasn't reached beyond OTC lotto trading community. It would be nice if Benzinga or some other higher profile stock news service picked up on the story. It's really a remarkable turnaround worthy of it.
Why you can be confident in RNVA earnings growth: https://www.hrsa.gov/sites/default/files/hrsa/opa/critical-access-hospital-factsheet.pdf
Current P/E only about 1 to 1. 10 to 1 P/E equals a price above .01 already. RNVA is rapidly growing into its share structure.
AS held in reserve as MA contingency. It represents shares of RNVA that could be issued to an MA partner.
"Lagan stated that he believed the revenues were sustainable and credited the management and employees with a continued focus on running an efficient operation which he expects to remain profitable."
Why I am confident in RNVA earnings growth: https://www.hrsa.gov/sites/default/files/hrsa/opa/critical-access-hospital-factsheet.pdf
Jay, let's say RNVAs annual earnings as we speak are only earnings $3 million, half of what one could reasonably project given the current growth trend. At the 30 billion share OS, that puts the current P/E ratio at 1 to 1. 10 to 1 is considered the low end for valuation purposes. The PPS is already more than reasonable, 1/10 of what is reasonable by standard measures. An RS to lock in an uplisting is one thing, but it would not help the stock get there. You are getting way ahead of yourself by talking RS now. One or two bargain hunters with a little cash can change the trading pattern in a flash.
The day isn't over yet. Squeeze that trigger Tom.
All their data on RNVA is years outdated or just plain wrong. Their methodology may be sound, but garbage in, garbage out.
With a float under 8 billion shares, the street could take over fairly quickly. You are right to point that out. By the numbers, RNVA is a strong buy, retail or commercial.
RNVA reported 1.3 million earnings in Q2 and climbing. It has operated in the black all year. You are just flat WRONG about dilution. Another RS any time in the near future would be totally unnecessary and counterproductive. When the stock is in pennies with an uplisting in sight, then we'll talk about a RS. It is about the P/E ratio going forward, which at 10 to 1 would yield a price above .001 TODAY!
There are NASDAQ listed companies today that would kill for a series of earnings reports like RNVA has filed.
I don't know why anyone wouldn't buy RNVA. The breakout Q2 earnings should have erased all doubt. Shares at .0001 are all gravy. My recommendation to all: Don't masturbate. Accumulate.
The CEO is on it. Most of Q2 earnings went to paying down debt.
There were lots of one-time charges associated with ceased operations and facility closures. The history, as I understand it, involved the merger of two companies losing money hand over fist due to overly optimistic business models into RNVA. After the merger, the CEO went about clearing away the dead wood and began playing to the remaining strengths and market opportunities. The federal CAH designation was a real difference maker.
Yes. About $300,000 plus $500,000 more from a legal settlement.
The swing bed expansion was only in effect for the last two weeks of Q2, but any front-end costs were included in the P/L. More revenue and earnings growth locked in through 2024.
To the extent preferred shareholders exercise common stock warrants, the effect on the OS will be negligible. Not a problem. We can put that bear trope to rest.
Clarifying language in Q2 10-K (page 15): "the following potential common stock equivalents were excluded from the calculation of diluted earnings (loss) per share as their effect was anti-dilutive." Translated, preferred shares suffered the same dilution as common shares or worse after RSs. For preferred shareholders, converting is like folding a poker hand late on a big pot and walking away from the table with a short stack. Common shareholders rule.
Opened this week. Should drive more revenue and earnings growth.
OTC traders mostly follow momentum related to flashy PR, MA rumors, and the next shiny object like HMBL that was never worth much to begin with. Value investors like myself are few and far between. RNVA has become a growth company, four quarters in a row of dynamic revenue growth now with breakout earnings. Larger interests outside of normal OTC trading are bound to move on RNVA at some point. The momentum traders will follow.
RNVA's value is above .001 based on current EPS.
Get out your calculator and assign whatever P/E ratio you think is appropriate.
At a P/E ratio of 10 to 1 or higher, RNVA's value is well above 000s just projecting flat earnings in Q3 and Q4! That's with the 30 billion OS. If earnings keep growing at anything close the current rate, we're headed for pennyland.
The 10-K shows most of Q2 earnings went to paying off debt. That will in turn improve earnings. I would rather the CEO do that before considering a stock buyback, but on the other hand, better to buyback at .0001 than somewhere higher. This scenario suggests all sorts of possibilities for improvement in the financial structure. I have never seen a .000 stock report revenue and earnings growth like this. Historically, the stock would have lifted off from .0001 long before now.
Earnings like these cure many ills: http://archive.fast-edgar.com/20230815/AA2ZUG2CZM2R8ZQZ2K2S2ZY2GPIKZZ22ZV52/
Maybe. Plenty of earnings to do it with. After all, it was this depressed OTC market that forced more dilution than should have been necessary in the first place after the last reverse split.
Q2 just out shows RNVA is rapidly growing into the share structure. We're going to see a breakout. Will have to churn through maybe 1.3 billion shares in volume to reach a .0002 bid, but the resistance will thin from there. If an RS is in the future, it will involve an uplisting.